HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: a mechanism to inhibit invasion.

Abstract
Neuroblastoma is the most frequent solid malignancy of children. The most reliable prognostic factor in neuroblastoma is the amplification status of the MYCN oncogene, but exceptions from this rule have been observed. Recently we have demonstrated that keratoepithelin (BIGH3, TGFBI) expression significantly reduces proliferation and invasion of neuroblastomas in vitro and in vivo. In these experiments, we also observed that tissue factor pathway inhibitor 2 (TFPI2, PP5, MSPI), a potent inhibitor of matrix-metalloproteinases, is most prominently up-regulated. As MYCN-amplified neuroblastomas are highly invasive, we sought to determine the interaction between MYCN, keratoepithelin and TFPI2. In this study we provide initial evidence that i) keratoepithelin expression in neuroblastoma inversely correlates with MYCN expression; ii) TFPI2 expression in neuroblastoma also correlates inversely with MYCN expression but positively with keratoepithelin expression and iii) keratoepithelin induces elevated TFPI2 transcript levels in neuroblastoma cells without alterations of MYCN expression.
AuthorsJuergen Becker, Sonja Volland, Ievgeniia Noskova, Alexander Schramm, Lothar L Schweigerer, Joerg Wilting
JournalInternational journal of oncology (Int J Oncol) Vol. 32 Issue 1 Pg. 235-40 (Jan 2008) ISSN: 1019-6439 [Print] Greece
PMID18097563 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Extracellular Matrix Proteins
  • Glycoproteins
  • MYCN protein, human
  • N-Myc Proto-Oncogene Protein
  • Nuclear Proteins
  • Oncogene Proteins
  • Transforming Growth Factor beta
  • tissue-factor-pathway inhibitor 2
  • betaIG-H3 protein
Topics
  • Cell Line, Tumor
  • Extracellular Matrix Proteins (physiology)
  • Gene Amplification
  • Glycoproteins (genetics, physiology)
  • Humans
  • N-Myc Proto-Oncogene Protein
  • Neoplasm Invasiveness
  • Neuroblastoma (pathology)
  • Nuclear Proteins (genetics, physiology)
  • Oncogene Proteins (genetics, physiology)
  • Oncogenes
  • Transforming Growth Factor beta (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: